IGVFFI9903UNGI

preview
validated
This object is in preview status. Metadata is subject to change until this object is released.
File Set
IGVFDS1824XDMU(prime editing Variant-EFFECTS targeting IL2RA: variant effects)
Summary
variant effects
File Format
tsv
Content Type
variant effects
Aliases
jesse-engreitz:IL2RA_promoter_tiling_Jurkat-Stimulation_Variant-EFFECTS_variant_effects_file
md5sum
c70af19b4e3199756fd218a8e694ee0b
Content MD5sum
4375dcd5287f75614e72b172c731717e
File Size
5.9 KB
Submitted File Name
IL2RA_promoter_tiling_Jurkat-Stimulation_AllelicEffectsStats.tsv.gz
Submitter Comment
output of Variant-EFFECTS (formerly known as Variant-FlowFISH) snakemake pipeline analyzing the effects of 5-bp promoter tiling mutagenesis edits on expression of IL2RA

File Format Specifications

1 item
Page
Description
Type
Download
Preview
explanation of columns in analysis summary file output by the Variant-EFFECTS pipeline
file format specification

Samples

25 items
Sample Terms
Summary
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 51-75% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 26-50% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 76-100% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 0-25% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 76-100% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 26-50% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 76-100% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 51-75% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 26-50% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library
InVitroSystem
Jurkat cell line, male, Homo sapiens (sorting details: FACS bin for 51-75% expression of IL2RA) treated with 100 ng/mL phorbol 13-acetate 12-myristate for 24 hours, 5 μg/mL T-cell surface glycoprotein CD3 gamma chain for 24 hours, modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2), transfected with a guide library

Files This File Derives From

784 items
fastq
reads
Jesse Engreitz, Stanford
2.0 MB
validated
fastq
reads
Jesse Engreitz, Stanford
2.0 MB
validated
fastq
reads
Jesse Engreitz, Stanford
11 MB
validated
fastq
reads
Jesse Engreitz, Stanford
1.7 MB
validated
fastq
reads
Jesse Engreitz, Stanford
2.3 MB
validated
fastq
reads
Jesse Engreitz, Stanford
2.3 MB
validated
fastq
reads
Jesse Engreitz, Stanford
9.2 MB
validated
fastq
reads
Jesse Engreitz, Stanford
2.2 MB
validated
fastq
reads
Jesse Engreitz, Stanford
2.0 MB
validated
fastq
reads
Jesse Engreitz, Stanford
1.6 MB
validated

Attribution